- Home
- XTNT vs ABOS Comparison
XTNT vs ABOS Comparison
Compare XTNT & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- ABOS
- Stock Information
- Founded
- XTNT N/A
- ABOS 1996
- Country
- XTNT United States
- ABOS United States
- Employees
- XTNT N/A
- ABOS N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- XTNT Health Care
- ABOS Health Care
- Exchange
- XTNT Nasdaq
- ABOS Nasdaq
- Market Cap
- XTNT 60.9M
- ABOS 72.7M
- IPO Year
- XTNT N/A
- ABOS 2021
- Fundamental
- Price
- XTNT $0.72
- ABOS $1.13
- Analyst Decision
- XTNT
- ABOS Strong Buy
- Analyst Count
- XTNT 0
- ABOS 4
- Target Price
- XTNT N/A
- ABOS $6.50
- AVG Volume (30 Days)
- XTNT 74.4K
- ABOS 571.8K
- Earning Date
- XTNT 08-07-2025
- ABOS 08-12-2025
- Dividend Yield
- XTNT N/A
- ABOS N/A
- EPS Growth
- XTNT N/A
- ABOS N/A
- EPS
- XTNT N/A
- ABOS N/A
- Revenue
- XTNT $122,298,000.00
- ABOS N/A
- Revenue This Year
- XTNT $11.64
- ABOS N/A
- Revenue Next Year
- XTNT $7.59
- ABOS N/A
- P/E Ratio
- XTNT N/A
- ABOS N/A
- Revenue Growth
- XTNT 20.81
- ABOS N/A
- 52 Week Low
- XTNT $0.33
- ABOS $0.86
- 52 Week High
- XTNT $0.83
- ABOS $3.60
- Technical
- Relative Strength Index (RSI)
- XTNT 67.35
- ABOS 48.75
- Support Level
- XTNT $0.60
- ABOS $1.12
- Resistance Level
- XTNT $0.78
- ABOS $1.26
- Average True Range (ATR)
- XTNT 0.05
- ABOS 0.08
- MACD
- XTNT 0.01
- ABOS -0.01
- Stochastic Oscillator
- XTNT 85.71
- ABOS 30.77
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.